A carregar...
Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis
BACKGROUND: Immune checkpoints target regulatory pathways in T cells that enhance antitumor immune responses and elicit durable clinical responses. As a novel immune checkpoint, CD96 is an attractive key target for cancer immunotherapy. However, there has been no integrative investigation of CD96 in...
Na minha lista:
| Publicado no: | Front Bioeng Biotechnol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7338376/ https://ncbi.nlm.nih.gov/pubmed/32695752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.00592 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|